- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 1st, 2005
Imagine a cancer drug that can burrow into a tumor, seal the exits and detonate a lethal dose of anticancer toxins, all while leaving healthy cells unscathed. Investigators at the Massachusetts Institute of Technology have designed a multifunctional nanoparticle to do just that. The dual-chamber, double-acting, drug-packing "nanocell" proved effective and safe, with prolonged survival, against two distinct forms of cancers-melanoma and Lewis lung cancer-in mice. This work, conducted by a multidisciplinary team led by Ram Sasisekharan, Ph.D., of MIT, was published in the journal Nature.
The nanocell worked better against melanoma than lung cancer, indicating the need to tweak the design for different cancers. "This model enables us to rationally and systematically evaluate drug combinations and loading mechanisms," says Dr. Sasisekharan. "It's not going to stop here. We want to build on this concept."
|Related News Press|
Designing ultrasound tools with Lego-like proteins August 29th, 2016
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
FEI Celebrates Shipment of 1,000th Helios DualBeam System: FEI’s Helios Family has lead the DualBeam technology race and is widely used across the semiconductor, materials science, life sciences and oil & gas industries August 31st, 2016
Diamonds and quantum information processing on the nano scale August 31st, 2016